The US Food and Drug Administration (FDA) said it has determined the shortage of semaglutide injection products, a glucagon-like peptide 1 (GLP-1) medication, is now resolved.

More than 15.5 million Americans have tried weight loss injectables, but risks are rising with the proliferation of ...

Weight loss injections have become incredibly popular in the last year or so. In fact, these medications are so widely used ...

Find Subcutaneous Needle stock video, 4K footage, and other HD footage from iStock. Get higher quality Subcutaneous Needle content, for less—All of our 4K video clips are the same price as HD. Video ...

Researchers said the study backs up anecdotal evidence from patients and doctors that semaglutide can lead to a sudden loss of longing for alcoholic drinks ...

A new study has found that semaglutide — the active substance in Ozempic and Wegovy — may help reduce alcohol cravings in people with AUD. Despite the availability of treatment options ...

A new generation of anti-obesity drugs aims for greater effectiveness, fewer side effects, and more convenience.

A trial exploring the use of a higher dose of Novo Nordisk's GLP-1 agonist semaglutide has shown that patients with obesity who were taking the drug were able to shed more than a fifth of their ...

Novo Nordisk's GLP-1 receptor agonist semaglutide has shown efficacy as a treatment for metabolic dysfunction-associated steatohepatitis (MASH) in a phase 3 trial, potentially teeing up US and ...

Wegovy and Ozempic have the same active ingredient, semaglutide. “Technically, they are exactly the same,” Dr. Maria Daniela Hurtado Andrade, an endocrinologist at the Mayo Clinic’s ...

Novo Nordisk reprimanded for allegedly failing to disclose payments - The manufacturer of the weight loss jab Wegovy said it ...